CANDOR Bioscience: Immunoassay Buffers: new eSHOP now open for business!

 

Now open: UK eShop CLICK HERE

Manufacturers and Developers of IVDs: Improve your Immunoassay Performance and Stability! Professional buffer solutions Made-in-Germany for better immunoassays to help you:

  • Enhance Sensitivity and improve Specificity with CANDOR Bioscience Buffer Solutions
  • Extend Shelf-life for antibodies, proteins, surface-bound or in solution with Liquid Plate Sealer®
  • Improve CV and Reliability by neutralizing cross-reactivities, matrix effects and non-specific binding with LowCross-Buffer®

Innaxon Synthetic CD14 / TLR4 Antagonists (IAXO)

                

                

IAXO compounds are Glycolipids and Benzylammonium Lipids designed to act as Lipid A antagonists that potently can inhibit the CD14 and Toll-like Receptor 4 (TLR4) receptors in vitro and in vivo and are innovative drug candidates with therapeutic activity in rodent models of (auto/sterile) inflammatory diseases, neuropathic pain and LPS (endotoxin) induced septic shock.

 

The novel family of synthetic IAXO compounds [see References] not only can inhibit LPS-stimulated TLR4 activation by competitively occupying CD14 and thereby reducing the delivery of activating endotoxin to MD-2-TLR4 but may also shed light on the features of CD14-dependent and TLR4-independent signalling pathways.

 

PEVIVA: Epithelial Cell Death Biomarker Assays

M30 Apoptosense ELISA M65 EpiDeath ELISA

 

 

 

 

PEVIVA's first-in-class CE-certified cell death biomarker assays M65 ELISA® and M30-Apoptosense® ELISA and the just launched novel broad measuring range version M65 EpiDeath ELISA® have been independently validated by pharmaceutical companies and clinical research centres for diagnostic use in oncology and hepatology.

"Development, production, marketing and sales of biomarker assays to be used for pre-clinical and clinical applications within the fields of hepatology, gastroenterology,organ transplantation, sepsis and cancer" from PEVIVA are quality-certified according to ISO 9001:2008 and ISO 13485:2003.

PEVIVA is the original developer and manufacturer of the well-established M30 CytoDEATHTM monoclonal antibody directed against the caspase-cleaved neo-epitope M30 of Keratin-18 (K18Asp396-NE, ccK18, K18F-M30). 

Use the PEVIVM30 CytoDEATHTM monoclonal antibody provided in a convenient, stabilized stock solution with the widest range of conjugates for FACS, IHC and CTC analysis.

Syndicate content